Latin America’s In Vitro Diagnostics (IVD) Market to Reach $4.2 Billion in 2025

By Daniel Granderson   The market for in vitro diagnostics (IVD) in Latin America, estimated at nearly $3.3 billion in 2020, is forecast to experience a 5.3% compound annual growth rate (CAGR) to reach $4.2 billion in 2025. The forecast growth rate for Latin America will therefore slightly outpace what’s expected for the world’s leading […]

What’s Trending: Rising Out-of-Pocket Healthcare Spending Has Media Abuzz

  “In 2021, total U.S. out-of-pocket healthcare spending by consumers reached an estimated $491.6 billion, up about 10% from the prior year with continued annual growth of 9.9% expected through 2026. This will result in almost $800 billion of consumer out-of-pocket healthcare spending in 2026.” – Kalorama Information’s Out-of-Pocket Healthcare Expenditures in the United States, […]

Infographic: In Vitro Diagnostics (IVD) in the U.S. and Latin America

Leading medical market research publisher Kalorama Information analyzes the IVD industry across multiple reports published in 2021, including the upcoming The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition, a 1,500-plus page report that has provided reliable estimates and real-world forecasts for two decades. The report is scheduled to publish in August. Previously published […]

U.S. Out-Of-Pocket Healthcare Spending Swells to $491 Billion, Up 10%

By Daniel Granderson   In 2021, total U.S. out-of-pocket healthcare spending by consumers reached an estimated $491.6 billion, up about 10% from the prior year with continued annual growth of 9.9% expected through 2026. This will result in almost $800 billion of consumer out-of-pocket healthcare spending in 2026, reports leading medical market research publisher Kalorama […]

Infographic: Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)

Learn more about this important market by subscribing to CELL AND GENE THERAPY BUSINESS OUTLOOK, a twice-monthly publication from the leaders at Kalorama Information. This is an exciting time for the cell and gene therapy industry. Its products are transforming the treatment of cancers and genetic diseases, as well as a host of other illnesses […]

$41 Billion U.S. In Vitro Diagnostics (IVD) Market to Grow 5% Through 2025

By Daniel Granderson   The IVD market’s growth in key segments in the U.S. has been accelerated due to the COVID-19 pandemic and the need for testing for the coronavirus. The United States is the largest healthcare market in the world with high privatization of payments relative to other major developed countries. The U.S. healthcare […]

COVID-19 Testing Increases Demand in $150 Billion Clinical Laboratory Services Market, Future Growth Linked to Global Economies

  The global market for clinical laboratory services grew to an estimated $150.4 billion during 2020, with COVID-19 testing demand increasing the market by more than $26 billion over the year. These findings are according to insights featured in Clinical Laboratory Services Market, 6th Edition, a new report by leading medical market research publisher Kalorama […]

Molecular Diagnostics Market to Reach 28 Billion. We Didn’t Predict That Two Years Ago.

The market for DNA-based tests used for clinical diagnostic purposes has exceeded previous forecasting, due to the COVID-19 crisis. Mid 2019, Kalorama Information’s report projected the market size (all DNA-based tests, revenues to IVD companies) would reach 10.1 billion.  We also estimated cancer would be the driver.  Instead, Kalorama now projects that market to be […]

Oncologists Urge Faster Biomarker Results for Lung Cancer Patients

Diagnostic testing companies should do a better job of turning around biomarker test results for lung cancer patients, according to a survey reported at the American Society of Clinical Oncology (ASCO) annual meeting on June 4. Out of 170 clinicians polled, the vast majority (98%) said that they felt it was important to get biomarker […]

China Emerging as Vital Point of Care (POC) Market

  Reforms in China, along with increasing incidence of cancer, diabetes, heart disease and infectious diseases such as HIV, hepatitis and STDs, provide new opportunities for point-of-care, advanced tests and molecular diagnostics, reports medical market research publisher Kalorama Information.   China’s potential as a point of care (POC) market was already growing when the coronavirus […]